Compare · NTRA vs TVTY
NTRA vs TVTY
Side-by-side comparison of Natera Inc. (NTRA) and Tivity Health Inc. (TVTY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NTRA and TVTY operate in Medical Specialities (Health Care), so they compete in similar markets.
- NTRA is the larger of the two at $47.61B, about 38.4x TVTY ($1.24B).
- NTRA has hit the wire 8 times in the past 4 weeks while TVTY has been quiet.
- NTRA has more recent analyst coverage (25 ratings vs 4 for TVTY).
- Company
- Natera Inc.
- Tivity Health Inc.
- Price
- -
- -
- Market cap
- $47.61B
- $1.24B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- News (4w)
- 8
- 0
- Recent ratings
- 25
- 4
Natera Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Tivity Health Inc.
Tivity Health, Inc. provides fitness and health products primarily for seniors and older adults in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine. It also provides Wisely Well brand meals designed to support individuals and caregivers who are seeking meal convenience, as well as those recovering after a hospitalization or living with chronic conditions. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was incorporated in 1981 and is headquartered in Franklin, Tennessee.
Latest NTRA
- UBS resumed coverage on Natera with a new price target
- Rothschild & Co Redburn initiated coverage on Natera with a new price target
- PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon sold $5,917,907 worth of shares (18,160 units at $325.88) as part of a pre-agreed trading plan, decreasing direct ownership by 14% to 110,859 units (SEC Form 4) to satisfy withholding tax
- CEO AND PRESIDENT Chapman Steven Leonard sold $545,041 worth of shares (1,698 units at $320.99) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 98,199 units (SEC Form 4)
- New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma
- PRESIDENT, CHIEF BUS. OFFICER Fesko John was granted 20,000 shares and sold $2,095,411 worth of shares (6,517 units at $321.53) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 197,257 units (SEC Form 4) (tax liability)
- Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
- Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
- CO-FOUNDER Sheena Jonathan sold $1,951,942 worth of shares (6,000 units at $325.32) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 230,464 units (SEC Form 4)
- Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers
Latest TVTY
- Fortrea to Add Erin L. Russell to Board of Directors
- Modivcare Announces Changes to Board of Directors
- SilverSneakers to Offer World Class Fitness Experience from Apple Fitness+ in 2023
- SilverSneakers Marks Three Decades of Providing Dynamic Health Improvement Solutions for Seniors
- WholeHealth Living to Partner with Vori Health to Provide Industry Leading Musculoskeletal Solution
- SilverSneakers Announces 2022 Member of the Year
- SEC Form 15-12G filed by Tivity Health Inc.
- Tivity Health Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 4: Wagers Ryan returned $956,150 worth of shares to the company (29,420 units at $32.50), closing all direct ownership in the company (tax withholding)
- SEC Form 4: Bilbao Joseph Raymond returned $961,708 worth of shares to the company (29,591 units at $32.50), closing all direct ownership in the company to cover withholding tax